Lipoxin A4 metabolites/analogues from two commercial sources have no effects on tnf-α-mediated priming or activation through the neutrophil formyl peptide receptors

Scandinavian Journal of Immunology

Volumn 70, Issue 4, 2009, Pages 396-402

  Forsman, H ^a   Dahlgren, C ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3 RECEPTOR; CYTOKINE; FORMYLPEPTIDE RECEPTOR; LIPOXIN A; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOLOGICAL ACTIVITY; CELL MOTILITY; HUMAN; HUMAN CELL; METABOLITE; NEUTROPHIL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CALCIUM SIGNALING; HEPTANOIC ACIDS; HUMANS; LIPOXINS; MACROPHAGE-1 ANTIGEN; MONOCYTES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NADPH OXIDASE; NEUTROPHIL ACTIVATION; NEUTROPHILS; OLIGOPEPTIDES; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70049114943     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02311.x     Document Type: Article

References (48)

1. Chiang N, Serhan CN, Dahlen SE et al. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 2006 58 : 463 487.
2. Fu H, Karlsson J, Bylund J, Movitz C, Karlsson A, Dahlgren C. Ligand recognition and activation of formyl peptide receptors in neutrophils. J Leukoc Biol 2006 79 : 247 256.
3. Ye RD, Boulay F. Structure and function of leukocyte chemoattractant receptors. Adv Pharmacol 1997 39 : 221 289.
4. Rabiet MJ, Huet E, Boulay F. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Biochimie 2007 89 : 1089 1106.
5. Migeotte I, Communi D, Parmentier M. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev 2006 17 : 501 519.
6. Christophe T, Karlsson A, Rabiet MJ, Boulay F, Dahlgren C. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4. Scand J Immunol 2002 56 : 470 476.
7. Chiang N, Fierro IM, Gronert K, Serhan CN. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med 2000 191 : 1197 1208.
8. Goh J, Baird AW, O'Keane C. Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo. J Immunol 2001 167 : 2772 2780.
9. Pouliot M, Serhan CN. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases. J Periodontal Res 1999 34 : 370 373.
10. Hachicha M, Pouliot M, Petasis NA, Serhan CN. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J Exp Med 1999 189 : 1923 1930.
11. Fu H, Karlsson J, Bjorkman L et al. Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-A tool in analysing receptor specific events. J Immunol Methods 2008 331 : 50 8.
12. Boyum A, Lovhaug D, Tresland L, Nordlie EM. Separation of leucocytes: Improved cell purity by fine adjustments of gradient medium density and osmolality. Scand J Immunol 1991 34 : 697 712.
13. Hellstrand K, Asea A, Dahlgren C, Hermodsson S. Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites. J Immunol 1994 153 : 4940 4947.
14. Zhang L, Wan J, Li H et al. Protective effects of BML-111, a lipoxin A(4) receptor agonist, on carbon tetrachloride-induced liver injury in mice. Hepatol Res 2007 37 : 948 956.
15. Lundahl J, Dahlgren C, Gustavsson K, Hed J. Serum protects against azurophil granule dependent down-regulation of complement receptor type 1 (CR1) on human neutrophils. Inflamm Res 1995 44 : 438 446.
16. Dahlgren C, Karlsson A. Respiratory burst in human neutrophils. J Immunol Methods 1999 232 : 3 14.
17. Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, Serhan CN. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J Biol Chem 1997 272 : 6972 6978.
18. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987 80 : 1550 1560.
19. Elbim C, Bailly S, Chollet-Martin S, Hakim J, Gougerot-Pocidalo MA. Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides. Infect Immun 1994 62 : 2195 2201.
20. Dang P. M., Stensballe A., Boussetta T et al. A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J Clin Invest 2006 116 : 2033 2043.
21. Bylund J, Pellme S, Fu H et al. Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils. BMC Cell Biol 2004 5 : 21.
22. Bjorkman L., Karlsson J., Karlsson A et al. Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1. J Leukoc Biol 2008 83 : 245 253.
23. Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res 2000 15 : 1459 1466.
24. Bae YS, Lee HY, Jo EJ et al. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J Immunol 2004 173 : 607 614.
25. Fu H, Bjorkman L, Janmey P et al. The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide. BMC Cell Biol 2004 5 : 50.
26. El Kebir D, Jozsef L, Khreiss T et al. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J Immunol 2007 179 : 616 622.
27. Parameswaran K, Radford K, Fanat A et al. Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines. Am J Respir Cell Mol Biol 2007 37 : 240 247.
28. Zhang L., Zhang X., Wu P et al. BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthitis. Inflamm Res 2008 57 : 157 162.
29. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat 2002 68-69 : 433 455.
30. Boulay F, Tardif M, Brouchon L, Vignais P. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem Biophys Res Commun 1990 168 : 1103 1109.
31. Ye RD, Cavanagh SL, Quehenberger O, Prossnitz ER, Cochrane CG. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem Biophys Res Commun 1992 184 : 582 589.
32. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol 2002 23 : 541 548.
33. Romano M, Maddox JF, Serhan CN. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization. J Immunol 1996 157 : 2149 2154.
34. Maddox JF, Serhan CN. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med 1996 183 : 137 146.
35. Palmblad J, Gyllenhammar H, Ringertz B, Serhan CN, Samuelsson B, Nicolaou KC. The effects of lipoxin A and lipoxin B on functional responses of human granulocytes. Biochem Biophys Res Commun 1987 145 : 168 175.
36. Serhan CN, Hamberg M, Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci U S A 1984 81 : 5335 5339. (Pubitemid 14048742)
37. Nigam S, Fiore S, Luscinskas FW, Serhan CN. Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: dissociation between lipid remodeling and adhesion. J Cell Physiol 1990 143 : 512 523.
38. Moores KE, Merritt JE. Lipoxin A4 elevates cytosolic calcium in human neutrophils. Eicosanoids 1991 4 : 89 94.
39. Bae YS, Park JC, He R et al. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. Mol Pharmacol 2003 64 : 721 730.
40. Fierro IM, Colgan SP, Bernasconi G et al. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J Immunol 2003 170 : 2688 2694.
41. Fiore S, Maddox JF, Perez HD, Serhan CN. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med 1994 180 : 253 260.
42. Machado FS, Johndrow JE, Esper L et al. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med 2006 12 : 330 334.
43. Stenfeldt AL, Karlsson J, Wenneras C, Bylund J, Fu H, Dahlgren C. Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation 2007 30 : 224 229.
44. Cassatella MA. Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999 73 : 369 509.
45. Simi A, Lerouet D, Pinteaux E, Brough D. Mechanisms of regulation for interleukin-1beta in neurodegenerative disease. Neuropharmacology 2007 52 : 1563 1569.
46. Kelk P, Claesson R, Chen C, Sjostedt A, Johansson A. IL-1beta secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin. Int J Med Microbiol 2008 298 : 529 541.
47. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003 5 : 1317 1327.
48. Borregaard N, Sorensen OE, Theilgaard-Monch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol 2007 28 : 340 345.